Skip to content

Drug interactions

Sofosbuvir-velpatasvir-voxilaprevir + Sotorasib

Severity: Moderate

Sofosbuvir-velpatasvir-voxilaprevir and Sotorasib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Sotorasib is a P-glycoprotein substrate that also induces CYP3A4 and may affect P-gp, so its effect on the HCV combination is uncertain and not well characterised. Any reduction in sofosbuvir or voxilaprevir exposure could compromise cure rates, while changes in sotorasib exposure are also possible.

What this interaction means in plain words

Sofosbuvir-velpatasvir-voxilaprevir and Sotorasib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Sofosbuvir-velpatasvir-voxilaprevir belongs to Anti Virals; Sotorasib belongs to Oncology.

Evidence level: Low

Why it happens

Sotorasib may modulate P-glycoprotein and CYP3A4, altering absorption of P-gp substrates; the direction and size of the effect are not firmly established.

What to do

If coadministration is needed, monitor HCV viral response and sotorasib tolerability. Consider alternative acid-reducing or HCV regimens if virologic response is inadequate.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Sofosbuvir-velpatasvir-voxilaprevir and Sotorasib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Sofosbuvir-velpatasvir-voxilaprevir with Sotorasib?

MediHelp rates the interaction as moderate. Sofosbuvir-velpatasvir-voxilaprevir and Sotorasib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Sotorasib is a P-glycoprotein substrate that also induces CYP3A4 and may affect P-gp, so its effect on the HCV combination is uncertain and not well characterised. Any reduction in sofosbuvir or voxilaprevir exposure could compromise cure rates, while changes in sotorasib exposure are also possible.

How serious is the interaction between Sofosbuvir-velpatasvir-voxilaprevir and Sotorasib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: If coadministration is needed, monitor HCV viral response and sotorasib tolerability. Consider alternative acid-reducing or HCV regimens if virologic response is inadequate.

What other medicines interact with Sofosbuvir-velpatasvir-voxilaprevir?

MediHelp also lists interactions of Sofosbuvir-velpatasvir-voxilaprevir with, for example, Fosphenytoin, Phenobarbital, Phenytoin. The full list is on the Sofosbuvir-velpatasvir-voxilaprevir page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in